<DOC>
	<DOC>NCT01601496</DOC>
	<brief_summary>The purpose of the study is to evaluate the safety and efficacy of the the FUSION™ Vascular Graft.</brief_summary>
	<brief_title>Evaluation of FUSION™ Vascular Graft for Above Knee Targets</brief_title>
	<detailed_description>This study is a prospective, single arm, multi-center study to evaluate the FUSION™ Vascular Graft patency at 30 days, 6 months, 1 year and post operative complications not associated with bypass patency.</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Peripheral arterial occlusive disease requiring treatment of the femoral artery Patient is not participating in other clinical trials that would conflict with this protocol Patient willing and able to have followup visits and exams Life expectancy of less than one year Patients treated with coumadin (warfarin) prior to baseline procedure Antiplatelet therapy within 7 days of baseline procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>